{"id":176302,"name":"HEMOPHILIA OF GEORGIA","slug":"hemophilia-of-georgia","state":"GA","country":"United States of America","description":"&#226;€‹Providing services & support to individuals with hemophilia and other bleeding disorders","totalSpending":640000,"filings":33,"yearlySpending":[{"year":2018,"income":80000},{"year":2019,"income":80000},{"year":2020,"income":80000},{"year":2021,"income":80000},{"year":2022,"income":80000},{"year":2023,"income":80000},{"year":2024,"income":80000},{"year":2025,"income":80000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["NELSON MULLINS RILEY & SCARBOROUGH"],"lobbyists":["JENNIFER PHARAOH"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to the 340B Drug Pricing Program and biomedical research","Issues related to the 340B Drug Pricing Program and biomedical research","Issues related to the 340B Drug Pricing Program, biomedical research and Medicare","Issues related to the 340B Drug Pricing Program, biomedical research and Medicare","Issues related to the 340B Drug Pricing Program, biomedical research and Medicare"]}